The Joint DIA/ICOS Conference on Cardiac Toxicity 2014 covers topics such as:
- Best management approaches to protecting cardiac tissues during aggressive cancer therapy
- Best methods of cardiotoxicity detection during early phase clinical trials
- Effective communication between drug developers and prescribers
- Mechanistic actions of developing cancer therapy to allow cardioprotection
- Optimal patient care between cardiology and oncology
The Joint DIA/ICOS Conference on Cardiac Toxicity 2014 brings together:
- Drug development and clinical research managers and associates
- Cardiology, oncology and primary care physicians, nurse practioners, and other allied providers
- Pharmaceutical physicians and medical directors
- Pharmacovigilance, drug safety and drug surveillance personnel
- Clinical pharmacology scientists
- Safety pharmacology and non-clinical scientists
- Biostatisticians
- Regulatory affairs officers
- Outsourcing and marketing managers
- Data managers